-
UnitedHealth Could Ditch Obamacare: What It Means For Traders
Friday, November 20, 2015 - 3:34pm | 461Read More...Shares of UnitedHealth Group Inc (NYSE: UNH) have been volatile in 2015 and up 12 percent year-to-date. Cantor Fitzgerald’s Joseph D. France maintained a Hold rating on the company with a price target of $135, while Leerink’s Ana Gupta maintained an Outperform rating on the company,...
-
Cantor Fitzgerald Raises Molina Healthcare PT, Notes Uncertainty Surrounding Pending Acquisitions
Thursday, September 3, 2015 - 9:29am | 244Read More...Molina Healthcare, Inc. (NYSE: MOH) shares are up 37 percent year-to-date, and are trading close to their 52-week high of $82.37. Cantor Fitzgerald analyst Joseph D. France maintained a Hold rating on the company, while raising the price target from $60 to $65. Uncertainty surrounding the...
-
2 Analysts Diverge On Humana Recommendations
Monday, June 1, 2015 - 2:29pm | 585Read More...Medicare's expected enrollment growth of 50 percent in the next 15 years makes Humana Inc (NYSE: HUM) a glittering prize in the health insurance industry. But a couple of analysts diverged Monday over whether to recommend Humana as a current investment. Humana, which gets about 85 percent of its...
-
UPDATE: Cantor Fitzgerald Initiates Coverage on Envision Healthcare on Market Leader Position
Monday, September 23, 2013 - 8:52am | 131Read More...In a report published Monday, Cantor Fitzgerald analyst Joseph D. France initiated coverage on Envision Healthcare Holdings (NYSE: EVHC) with a Buy rating and $32.00 price target. In the report, Cantor Fitzgerald noted, “We are introducing coverage of Envision Healthcare Holdings, Inc. with a BUY...
-
UPDATE: Cantor Fitzgerald Initiates Ensign Group at Buy on Attractive Growth
Friday, June 14, 2013 - 8:41am | 173Read More...In a report published on Friday, Cantor Fitzgerald analyst Joseph D. France initiated coverage on Ensign Group (NASDAQ: ENSG) with a Buy rating and a $40 price target. In the report, Cantor Fitzgerald commented that, "Ensign's compound annual EPS growth has been 17.6% since its 2007 IPO, and...
